Frontiers in Cardiovascular Medicine

JUNE 30, 2024

Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Myocardial Infarction Aneurysm 52

Frontiers in Cardiovascular Medicine

OCTOBER 10, 2024

and improved patients’ quality of life scores. The intergroup comparison showed the therapeutic effect of the combination was equivalent in HF caused by myocardial Infarction (MI), dilated cardiomyopathy (DCM) or Valvular Heart Disease (VHD).ConclusionVericiguat

Heart Failure 52

Heart Failure Preserved Ejection Fraction Cardiac Function Quality of Life 52

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Patients underwent a comprehensive angiological screening, which included blood serum analysis, assessment of medical and family history, cardiovascular risk, and disease status, and evaluation of lifestyle and quality of life. vs. 53.2%, p  = 0.014) and myocardial infarction (24.7% vs. 45.8%; 17.6% vs. 5.5.%,

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease 59

Open Heart

MARCH 1, 2024

Introduction Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).

Blood Pressure 40

Blood Pressure Education Hypertension Quality of Life 40

DAIC

OCTOBER 1, 2024

I believe that PlaqueIQ will enable physicians to better ‘see’ the disease—specifically plaque quantity and type—so that we can treat patients with greater precision and in personalized manner, improve their quality of life, and ultimately prevent MI and stroke more effectively.”

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

Journal of the American Heart Association

JANUARY 16, 2024

Key secondary and exploratory outcomes include improvement in a composite cardiovascular health metric, CR engagement, quality of life, health factors (including low‐density lipoprotein‐cholesterol, hemoglobin A1c, weight, diet, smoking cessation, blood pressure), and psychosocial factors.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Technology Cardiac Rehabilitation Quality of Life 40

Dr. Smith's ECG Blog

MARCH 17, 2024

Answer: This is MINOCA -- Myocardial Infarction with Non-Obstructive Coronary Arteries. Comprehensive coronary evaluation (with testing for vasospasm and microvascular dysfunction) was shown in the randomized trial CorMicA to significantly improve angina, quality of life, and diagnostic accuracy.

Angina 70

Angina Chest Pain Blog Ischemia 70

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

These methods only alleviate symptoms of heart failure and myocardial ischemia and improve patients' quality of life by partially restoring myocardial reperfusion. The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI).

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Open Heart

JANUARY 17, 2024

Objective In the COVERT-MI randomised placebo-controlled trial, oral administration of high-dose colchicine at the time of reperfusion and for 5 days in acute ST-elevated myocardial infarction did not reduce infarct size but was associated with a significant increase in left ventricular thrombus (LVT) in comparison to placebo.

Myocardial Infarction 96

Myocardial Infarction Quality of Life Heart Failure Stroke 96

Open Heart

AUGUST 21, 2023

Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are limited.

Myocardial Infarction 52

Myocardial Infarction Angina Outcomes Coronary Artery Disease 52

DAIC

SEPTEMBER 11, 2024

“Atrial fibrillation doubles the risk of mortality, is one of the most common causes of stroke, increases risks of heart failure, myocardial infarction, chronic kidney disease and dementia, and results in lower quality of life,” said first author Jean Jacques Noubiap, MD, PhD, a postdoctoral scholar at UCSF with a specialty in global cardiovascular (..)

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

DAIC

JUNE 12, 2024

RWMAs can be an independent indicator of adverse cardiovascular events and death in patients with cardiovascular diseases like myocardial infarction (MI) and congenital heart disease. It's also associated with high mortality and poor quality of life, and is a substantial burden on healthcare systems globally 2.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

Dr. Paddy Barrett

JANUARY 30, 2024

MI = Myocardial Infarction/Heart Attack However, there are two very important caveats. Secondly, even with a normal cardiac CT, their risk factor profile will likely impact their quality of life over time. 2023, 2 Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. So a very low chance.

Heart Disease 95

Heart Disease Heart Attack Heart attacks Plaque 95

American College of Cardiology

AUGUST 30, 2024

Interruption of beta-blocker treatment in patients with a history of myocardial infarction (MI) did not reduce risk of cardiovascular events or death, nor did it appear to improve quality of life compared with continuation of treatment.

Quality of Life 40

Quality of Life Myocardial Infarction Article 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions. The primary outcome is a hierarchical composite of all-cause death, stroke, spontaneous myocardial infarction, cardiovascular hospitalization, and periprocedural myocardial infarction, analyzed using the win ratio.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

The New England Journal of Medicine

DECEMBER 20, 2023

The primary aim of treating patients with stable angina is to decrease symptoms and improve quality of life. Percutaneous coronary intervention (PCI), a treatment for patients with angina, does not reduce the risk of death from any cause, death from cardiac causes, or myocardial infarction.1 1 In this issue.

Angina 40

Angina Quality of Life Myocardial Infarction 40

DAIC

SEPTEMBER 11, 2024

“Atrial fibrillation doubles the risk of mortality, is one of the most common causes of stroke, increases risks of heart failure, myocardial infarction, chronic kidney disease and dementia, and results in lower quality of life,” said first author Jean Jacques Noubiap, MD, PhD, a postdoctoral scholar at UCSF with a specialty in global cardiovascular (..)

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

CardiacWire

SEPTEMBER 8, 2024

Results from the ABYSS trial surprised many at ESC 2024, finding that patients who continue beta-blocker therapy after heart attacks have better long-term outcomes than patients who stop taking the drugs, and they don’t experience the quality of life downsides that some might expect. vs. 2.5%), and stroke (1% vs. 1%).

Heart Attack 59

Heart Attack Heart attacks Quality of Life Hospital 59

Wellnest

DECEMBER 11, 2023

Prevention of Opportunistic Infections: Reduced Opportunistic Infections: ART significantly lowers the risk of opportunistic infections, such as pneumonia, tuberculosis, and fungal infections, which can be life-threatening in individuals with compromised immune systems. million lives lost to HIV and an estimated 39.0

Quality of Life 52

Quality of Life Myocardial Infarction Public Health Arrhythmia 52

DAIC

APRIL 8, 2024

What we see today is more myocardial infarctions that are smaller and that do not damage the heart muscle to the same extent.” The researchers plan to separately analyze outcomes related to quality of life and sexual health.

Heart Attack 52

Heart Attack Heart attacks Heart Failure Myocardial Infarction 52

Cardiometabolic Health Congress

FEBRUARY 1, 2024

A rate of 15% of major depressive disorder has been reported in patients after myocardial infarction or coronary artery bypass grafting, and this rate is >20% in patients with heart failure and is much higher in advanced heart failure.” Indeed, several studies have reported higher rates of depression among people with CVD.

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

MIBHS

DECEMBER 13, 2024

Risk Factors for ED: Heart disease, specifically coronary artery disease (CAD) and acute myocardial infarction (AMI), is closely linked to male erectile dysfunction. By working closely with healthcare providers, patients can manage both their heart disease and erectile dysfunction, leading to better overall health and quality of life.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Diet Heart Disease Risk Factors 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations The Annals of Thoracic Surgery November 2018 Alice Wang Robotic Mitral Valve Repair in Older Individuals: An Analysis of The Society of Thoracic Surgeons Database The Annals of Thoracic Surgery November 2018 Mohamad Alaeddine Aortic clamping strategy (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations The Annals of Thoracic Surgery November 2018 Alice Wang 1 Robotic Mitral Valve Repair in Older Individuals: An Analysis of The Society of Thoracic Surgeons Database The Annals of Thoracic Surgery November 2018 Mohamad Alaeddine 1 Aortic clamping (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Open Heart

AUGUST 12, 2024

Objectives Sex differences occur in atrial fibrillation (AF), including age at first manifestation, pathophysiology, treatment allocation, complication rates and quality of life. However, optimal doses of cardiovascular pharmacotherapy used in women with AF with or without heart failure (HF) are unclear.

Atrial Fibrillation 52

Atrial Fibrillation Outcomes Quality of Life Myocardial Infarction 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

What better way to join the fall festivities than by spotlighting key insights in cardiorenal metabolic medicine, primary prevention, and quality of life improvements shared at this year’s biggest U.S. cardiometabolic health CME/CE conference: the 19th Annual CMHC.

CME 103

CME Obesity Heart Failure Biomarkers 103